Recurrent and non-recurrent mutations of SCN8A in epileptic encephalopathy

Frontiers in Neurology

Volumn 6, Issue MAY, 2015, Pages

  Wagnon, Jacy L ^a   Meisler, Miriam H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

CpG; Dravet syndrome; Epilepsy; Mutation; Seizures; Sodium channel; SUDEP

Indexed keywords

CARBAMAZEPINE; CORTICOTROPIN; CPG OLIGODEOXYNUCLEOTIDE; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LIDOCAINE; MIDAZOLAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL NAV1.6; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

BRAIN DISEASE; COGNITIVE DEFECT; DEVELOPMENTAL DISORDER; DISEASE EXACERBATION; DNA SEQUENCE; EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY; EPILEPSY; GENETIC CONSERVATION; HUMAN; MISSENSE MUTATION; MOTOR DYSFUNCTION; NONHUMAN; ONSET AGE; PROTEIN STRUCTURE; REVIEW; SEIZURE; SUDDEN DEATH;

EID: 84930641362     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00104     Document Type: Review

References (53)

1. Catterall WA. Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol (2012) 590:2577-89. doi: 10.1113/jphysiol.2011.224204.
2. Meisler MH, O'brien JE, Sharkey LM. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J Physiol (2010) 588:1841-8. doi:10.1113/jphysiol.2010.188482.
3. O'Brien JE, Meisler MH. Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability. Front Genet (2013) 4:213. doi:10.3389/fgene.2013.00213.
4. Caldwell JH, Schaller KL, Lasher RS, Peles E, Levinson SR. Sodium channel Na(v)1.6 is localized at nodes of Ranvier, dendrites, and synapses. Proc Natl Acad Sci U S A (2000) 97:5616-20. doi:10.1073/pnas.090034797.
5. Lorincz A, Nusser Z. Cell-type-dependent molecular composition of the axon initial segment. J Neurosci (2008) 28:14329-40. doi:10.1523/JNEUROSCI.4833-08.2008.
6. Li T, Tian C, Scalmani P, Frassoni C, Mantegazza M, Wang Y, et al. Action potential initiation in neocortical inhibitory interneurons. PLoS Biol (2014) 12:e1001944. doi:10.1371/journal.pbio.1001944.
7. Tian C, Wang K, Ke W, Guo H, Shu Y. Molecular identity of axonal sodium channels in human cortical pyramidal cells. Front Cell Neurosci (2014) 8:297. doi:10.3389/fncel.2014.00297.
8. Hu W, Tian C, Li T, Yang M, Hou H, Shu Y. Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation. Nat Neurosci (2009) 12:996-1002. doi:10.1038/nn.2359.
9. Kearney JA, Buchner DA, De Haan G, Adamska M, Levin SI, Furay AR, et al. Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Hum Mol Genet (2002) 11:2765-75. doi:10.1093/hmg/11.22.2765.
10. McKinney BC, Chow CY, Meisler MH, Murphy GG. Exaggerated emotional behavior in mice heterozygous null for the sodium channel Scn8a (Nav1.6). Genes Brain Behav (2008) 7:629-38. doi:10.1111/j.1601-183X.2008.00399.x.
11. Papale LA, Paul KN, Sawyer NT, Manns JR, Tufik S, Escayg A. Dysfunction of the Scn8a voltage-gated sodium channel alters sleep architecture, reduces diurnal corticosterone levels, and enhances spatial memory. J Biol Chem (2010) 285:16553-61. doi:10.1074/jbc.M109.090084.
12. Papale LA, Beyer B, Jones JM, Sharkey LM, Tufik S, Epstein M, et al. Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in mice. Hum Mol Genet (2009) 18:1633-41. doi:10.1093/hmg/ddp081.
13. Trudeau MM, Dalton JC, Day JW, Ranum LP, Meisler MH. Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation. J Med Genet (2006) 43:527-30. doi:10.1136/jmg.2005.035667.
14. Sharkey LM, Jones JM, Hedera P, Meisler MH. Evaluation of SCN8A as a candidate gene for autosomal dominant essential tremor. Parkinsonism Relat Disord (2009) 15:321-3. doi:10.1016/j.parkreldis.2008.06.010.
15. Veeramah KR, O'Brien JE, Meisler MH, Cheng X, Dib-Hajj SD, Waxman SG, et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet (2012) 90:502-10. doi:10.1016/j.ajhg.2012.01.006.
16. Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet (2012) 380:1674-82. doi:10.1016/S0140-6736(12)61480-9.
17. Carvill GL, Heavin SB, Yendle SC, Mcmahon JM, O'Roak BJ, Cook J, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet (2013) 45:825-30. doi:10.1038/ng.2646.
18. Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, et al. De novo mutations in epileptic encephalopathies. Nature (2013) 501:217-21. doi:10.1038/nature12439.
19. Vaher U, Noukas M, Nikopensius T, Kals M, Annilo T, Nelis M, et al. De novo SCN8A mutation identified by whole-exome sequencing in a boy with neonatal epileptic encephalopathy, multiple congenital anomalies, and movement disorders. J Child Neurol (2013) 29:202-6. doi:10.1177/0883073813511300.
20. de Kovel CG, Meisler MH, Brilstra EH, Van Berkestijn FM, Van 'T Slot R, Van Lieshout S, et al. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy. Epilepsy Res (2014) 108:1511-8. doi:10.1016/j.eplepsyres.2014.08.020.
21. Dyment DA, Tetreault M, Beaulieu CL, Hartley T, Ferreira P, Warman Chardon J, et al. Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective study. Clin Genet (2014). doi:10.1111/cge.12464.
22. Estacion M, O'Brien JE, Conravey A, Hammer MF, Waxman SG, Dib-Hajj SD, et al. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy. Neurobiol Dis (2014) 69:117-23. doi:10.1016/j.nbd.2014.05.017.
23. Ohba C, Kato M, Takahashi S, Lerman-Sagie T, Lev D, Terashima H, et al. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia (2014) 55:994-1000. doi:10.1111/epi.12668.
24. Blanchard MG, Willemsen MH, Walker JB, Dib-Hajj SD, Waxman SG, Jongmans MC, et al. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. J Med Genet (2015) 52:330-7. doi:10.1136/jmedgenet-2014-102813.
25. Larsen J, Carvill GL, Gardella E, Kluger G, Schmiedel G, Barisic N, et al. The phenotypic spectrum of SCN8A encephalopathy. Neurology (2015) 84:480-9. doi:10.1212/WNL.0000000000001211.
26. Mercimek-Mahmutoglu S, Patel J, Cordeiro D, Hewson S, Callen D, Donner EJ, et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. Epilepsia (2015). doi:10.1111/epi.12954.
27. Singh R, Jayapal S, Goyal S, Jungbluth H, Lascelles K. Early-onset movement disorder and epileptic encephalopathy due to de novo dominant SCN8A mutation. Seizure (2015) 26:69-71. doi:10.1016/j.seizure.2015.01.017.
28. The Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature (2015) 519:223-8. doi:10.1038/nature14135.
29. Kearney JA, Wiste AK, Stephani U, Trudeau MM, Siegel A, Ramachandrannair R, et al. Recurrent de novo mutations of SCN1A in severe myoclonic epilepsy of infancy. Pediatr Neurol (2006) 34:116-20. doi:10.1016/j.pediatrneurol.2005.07.009.
30. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet (2013) 9:e1003709. doi:10.1371/journal.pgen.1003709.
31. Spampanato J, Kearney JA, De Haan G, Mcewen DP, Escayg A, Aradi I, et al. A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction. J Neurosci (2004) 24:10022-34. doi:10.1523/JNEUROSCI.2034-04.2004.
32. Liu CJ, Dib-Hajj SD, Renganathan M, Cummins TR, Waxman SG. Modulation of the cardiac sodium channel Nav1.5 by fibroblast growth factor homologous factor 1B. J Biol Chem (2003) 278:1029-36. doi:10.1074/jbc.M207074200.
33. Wittmack EK, Rush AM, Craner MJ, Goldfarb M, Waxman SG, Dib-Hajj SD. Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of Ranvier of dorsal root axons. J Neurosci (2004) 24:6765-75. doi:10.1523/JNEUROSCI.1628-04.2004.
34. Laezza F, Lampert A, Kozel MA, Gerber BR, Rush AM, Nerbonne JM, et al. FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. Mol Cell Neurosci (2009) 42:90-101. doi:10.1016/j.mcn.2009.05.007.
35. Bahler M, Rhoads A. Calmodulin signaling via the IQ motif. FEBS Lett (2002) 513:107-13. doi:10.1016/S0014-5793(01)03239-2.
36. Escayg A, Macdonald BT, Meisler MH, Baulac S, Huberfeld G, An-Gourfinkel I, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet (2000) 24:343-5. doi:10.1038/74159.
37. Lossin C, Wang DW, Rhodes TH, Vanoye CG, George AL Jr. Molecular basis of an inherited epilepsy. Neuron (2002) 34:877-84. doi:10.1016/S0896-6273(02)00714-6.
38. Rhodes TH, Lossin C, Vanoye CG, Wang DW, George AL Jr. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad Sci U S A (2004) 101:11147-52. doi:10.1073/pnas.0402482101.
39. Kearney JA, Plummer NW, Smith MR, Kapur J, Cummins TR, Waxman SG, et al. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience (2001) 102:307-17. doi:10.1016/S0306-4522(00)00479-6.
40. Sugawara T, Tsurubuchi Y, Agarwala KL, Ito M, Fukuma G, Mazaki-Miyazaki E, et al. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A (2001) 98:6384-9. doi:10.1073/pnas.111065098.
41. Liao Y, Anttonen AK, Liukkonen E, Gaily E, Maljevic S, Schubert S, et al. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain. Neurology (2010) 75:1454-8. doi:10.1212/WNL.0b013e3181f8812e.
42. Liao Y, Deprez L, Maljevic S, Pitsch J, Claes L, Hristova D, et al. Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy. Brain (2010) 133:1403-14. doi:10.1093/brain/awq057.
43. Lauxmann S, Boutry-Kryza N, Rivier C, Mueller S, Hedrich UB, Maljevic S, et al. An SCN2A mutation in a family with infantile seizures from Madagascar reveals an increased subthreshold Na(+) current. Epilepsia (2013) 54:e117-21. doi:10.1111/epi.12241.
44. Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, Blankston JR, et al. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neurosci Lett (2008) 433:65-70. doi:10.1016/j.neulet.2007.12.064.
45. Estacion M, Gasser A, Dib-Hajj SD, Waxman SG. A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons. Exp Neurol (2010) 224:362-8. doi:10.1016/j.expneurol.2010.04.012.
46. Spampanato J, Escayg A, Meisler MH, Goldin AL. Generalized epilepsy with febrile seizures plus type 2 mutation W1204R alters voltage-dependent gating of Na(v)1.1 sodium channels. Neuroscience (2003) 116:37-48. doi:10.1016/S0306-4522(02)00698-X.
47. Rhodes TH, Vanoye CG, Ohmori I, Ogiwara I, Yamakawa K, George AL Jr. Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures. J Physiol (2005) 569:433-45. doi:10.1113/jphysiol.2005.094326.
48. Ogiwara I, Ito K, Sawaishi Y, Osaka H, Mazaki E, Inoue I, et al. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology (2009) 73:1046-53. doi:10.1212/WNL.0b013e3181b9cebc.
49. Sokolov S, Scheuer T, Catterall WA. Gating pore current in an inherited ion channelopathy. Nature (2007) 446:76-8. doi:10.1038/nature05598.
50. Gosselin-Badaroudine P, Keller DI, Huang H, Pouliot V, Chatelier A, Osswald S, et al. A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype. PLoS One (2012) 7:e38331. doi:10.1371/journal.pone.0038331.
51. Jones JM, Meisler MH. Modeling human epilepsy by TALEN targeting of mouse sodium channel Scn8a. Genesis (2014) 52:141-8. doi:10.1002/dvg.22731.
52. Wagnon JL, Korn MJ, Parent R, Tarpey TA, Jones JM, Hammer MF, et al. Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy. Hum Mol Genet (2015) 24:506-15. doi:10.1093/hmg/ddu470.
53. Kong W, Zhang Y, Gao Y, Liu X, Gao K, Xie H, et al. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability. Epilepsia (2015) 56:431-8.